04/18/2024
3:21 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:31 PM | Pieris Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
7:00 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:12 PM | Checkpoint Capital L.P. (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:19 AM | Lynx1 Capital Management LP (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
8:59 AM | Pieris Pharmaceuticals (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
12/21/2023
3:30 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/14/2023
3:02 PM | Pieris Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023
3:49 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/18/2023
8:15 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
6:30 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
4:25 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:45 PM | Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:45 PM | Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Sherman Matthew L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:45 PM | Pieris Pharmaceuticals (Issuer)
Pieris Pharmaceuticals (Issuer)
Said Maya R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:45 PM | Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:45 PM | Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Richman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:46 PM | Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:46 PM | KIRITSY CHRISTOPHER P (Reporting)
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:46 PM | Kiener Peter A (Reporting)
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:46 PM | Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:46 PM | GERAGHTY JAMES A (Reporting)
GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:47 PM | Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
6:00 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
5:01 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
3:21 PM | KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:47 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13D | |
05/10/2023
6:30 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
